Independent director steps down from Bandhan Bank board
Bandhan Bank Limited disclosed the resignation of Santanu Mukherjee from his position as an independent director, effective December 16, 2025. The resignation, communicated via email on December 15, 2025, is attributed to "personal reasons," with no other material reasons stated.
Mukherjee holds several other directorships and committee memberships in listed entities. He serves as an independent director at Aurobindo Pharma Ltd, where he is a member of the Audit, Stakeholders Relationship, Risk Management, and ESG Committees, and chairman of the Nomination & Remuneration and IT Stewardship Committees.
Additionally, Mukherjee is an independent director at Suven Life Sciences Limited, serving as chairman of the Audit, Nomination & Remuneration, and Risk Management Committees. He also chairs the Audit and Nomination & Remuneration Committees at Sumedha Fiscal Services Ltd and is an independent director at Rainbow Children's Medicare Limited, chairing the Audit, Risk Management, and Nomination & Remuneration Committees, and serving as a member of the Corporate Social Responsibility Committee.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Bandhan Bank publishes news
Free account required • Unsubscribe anytime